CEACAM5 and colorectal carcinoma: Increased CEA (≥6 ng/mL) was found in 1/6 (16.7%) patients in the non-advanced adenoma group, 9/54 (16.7%) in the advanced adenoma group, and 17.6% (3/17) in the CRC group.